-
公开(公告)号:CS225991A3
公开(公告)日:1992-06-17
申请号:CS225991
申请日:1991-07-19
Applicant: HOECHST AG
IPC: A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/425 , A61K31/44 , A61K31/495 , A61K31/505 , A61P1/16 , A61P9/00 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/12 , A61P43/00 , C07D233/56 , C07D233/90 , C07D403/10 , C07D413/10 , C07D417/10 , C07D417/12 , C07D471/04 , C07D473/00 , C07D487/04 , C07D498/04 , C07D513/04 , C07D207/325 , C07D231/12 , C07D233/54 , C07D249/04 , C07D249/08 , C07D257/04 , A61K31/40 , A61K31/41
Abstract: Substd. azole derivs. of formula (I) and their physiologically acceptable salts are new. In (I) X, Y and Z are each N or CR2 R1 is 2-10C alkyl, 3-10C alkenyl, 3-10C alkynyl, -(CH2)mB(CH2nR4 (these 4 gps. opt. monosubstd. with CO2R3 and opt. have 1-all H atoms replaced by F), OR3, 3-8C cycloalkyl, 5-10C cycloalkylalkynyl, or benzyl (opt. mono or disubstd. on the Ph ring with halogen, 1-4C alkoxy and/or NO2), R2 = H, halogen, CvF2v+1, SF5, pentafluoro phenyl CN, phenyl, -(CH2)nF, -(CH2)nONO2, -CH2N3, -(CH2)nNO2, phthalimido (CH2)n-, R3 = H, 1-8C alkyl (in which 1 to all H are replaced by F), 3-8C cycloalkyl, Ph or benzyl, R4 = H, 1-6C alkyl, 3-8C cycloalkyl, 2-4C alkenyl, or 2-4C alkynyl, A = a mono or bicyclic unsatd. or partially hydrogenated heterocycle gp. with 5-10 ring atom of which up to 9 are C, and opt. substd. with up to 3 opt. different R14 gps. or -(CH2)n-1-(CHR6CH2)0-1, R14 where R14 = halogen, oxo, nitroso, NO2, amino, CN, OH, 1-6C alkyl, 1-4C alkanoyl, 1-4C alkanoyloxy. B = O, NR7 or S, W = O or S, L = 1-3C alkanediyl, R26 and R27 are each H, halogen, NO2, 1-4C alkyl or 1-2C alkoxy, n = 1-5, o = 1-10, q = 0-1.
-
公开(公告)号:CS368890A3
公开(公告)日:1992-02-19
申请号:CS368890
申请日:1990-07-24
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJORG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMES WERNER DR
IPC: C12N9/99 , A61K31/38 , A61K31/381 , A61K31/415 , A61K31/445 , A61K31/535 , A61K38/55 , A61P9/12 , C07C237/08 , C07C237/22 , C07D211/26 , C07D211/58 , C07D233/54 , C07D233/64 , C07D295/20 , C07D333/24 , C07D401/12 , C07D403/12 , C07D409/12 , C07D521/00 , C07K1/113 , C07K5/06 , C07K5/065 , C07K5/078 , C07K14/81
Abstract: The present invention relates to compounds of the formula I in which A, R , R , R and n are defined as indicated in the description, to processes for the preparation thereof, to the use thereof as medicines and to pharmaceutical compositions containing these.
-
公开(公告)号:DE4010797A1
公开(公告)日:1991-10-10
申请号:DE4010797
申请日:1990-04-04
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , HENNING RAINER DR , GERHARDS HERMANN DR , SCHOELKENS BERNWARD PROF DR
IPC: A61K31/415 , A61K31/38 , A61K31/40 , A61K31/41 , A61K31/4155 , A61K31/4164 , A61K31/423 , A61K31/437 , A61K31/44 , A61K31/443 , A61K31/4433 , A61K31/495 , A61K31/505 , A61K31/519 , A61P9/12 , A61P29/00 , A61P43/00 , C07D233/64 , C07D233/84 , C07D233/90 , C07D403/06 , C07D405/06 , C07D409/06 , C07D409/14 , C07D413/06 , C07D471/04 , C07D487/04
Abstract: The invention relates to compounds of the formula in which X, Y and Z are identical or different and are N or CR , R and R are as defined in the description, L is an alkylene radical, q = 0 or 1, and A is the radical of a fused heterobicycle. The invention furthermore relates to a method for the preparation of the abovementioned compounds, to compositions containing them, and to their use.
-
公开(公告)号:DE3932817A1
公开(公告)日:1991-04-11
申请号:DE3932817
申请日:1989-09-30
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJOERG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMER WERNER DR DR
IPC: C07D233/54 , C07D401/12 , C07D403/12 , C07D409/12 , C07K5/065 , C07K5/078
Abstract: Peptide polyhydroxyalkylamides of formula (I) and their salts are new; where A = R1R6N-CHR5-CO-, R1R7CH-CHR5-CO- or R1O-CHR5-CO-; R1 = R'1 or R'1W; R'1 = (a) 3-8C cycloalkyl, CONH2, OCH2COOH, NH2, etc. (b) H, OH or 1-4C alkoxy, (c) 1-18C alkyl, quanidino, phenyl(1-4C)alkoxy, etc. (d) 6-14C aryl, (6-14C)aryl(1-4C)alkyl, etc. (e) Het or Het(1-4C)alkyl, where Het is an opt. benzo-fused 5- to 7-membered heterocyclic ring contg. 1 or 2 of N, O, S, No, etc. (f) NR8R9; Het or Het(1-4C)alkyl, or NR8R9 is a mono- or bicyclic 5- to 12-membered ring system opt. contg. 1 or 2 more N atoms, an S atom or an O atom, opt. substd. by 1-4C alkyl; W = CO, CS, OSO, SO2, SO, NHSO2, NHCO, CHOH or NOH; n = 2-10.
-
公开(公告)号:DE3610593A1
公开(公告)日:1987-10-01
申请号:DE3610593
申请日:1986-03-29
Applicant: HOECHST AG
Inventor: WEGMANN HELMUT DR , WAGNER ADALBERT DR , KLEEMANN HEINZ-WERNER DR , RUPPERT DIETER DR
IPC: C07K14/81 , A61K31/165 , A61K31/18 , A61K31/195 , A61K31/215 , A61K31/22 , A61K31/235 , A61K31/255 , A61K31/27 , A61P9/12 , A61P43/00 , C07C67/00 , C07C231/00 , C07C231/02 , C07C231/12 , C07C237/06 , C07C237/12 , C07C237/20 , C07C237/22 , C07C239/00 , C07C301/00 , C07C303/30 , C07C303/36 , C07C309/76 , C07C311/37 , C07C313/00 , C07C317/48 , C07C317/50 , C07C323/41 , C07D213/38 , C07D233/54 , C07D233/61 , C07D233/64 , C07D521/00 , C07K1/113 , C07K5/02 , C07K5/06 , A61K37/64 , C07D213/40
-
公开(公告)号:AT252567T
公开(公告)日:2003-11-15
申请号:AT97107623
申请日:1997-05-09
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , HEITSCH HOLGER DR , NOELKEN GERHARD DR , WIRTH KLAUS DR , SCHOELKENS BERNWARD PROF DR
IPC: C07D277/60 , A61K31/38 , A61K31/395 , A61K31/41 , A61K31/425 , A61K31/428 , A61K31/53 , A61P43/00 , C07D253/10 , C07D277/62 , C07D277/64 , C07D277/66 , C07D277/68 , C07D277/70 , C07D277/74 , C07D277/82 , C07D417/12
Abstract: Sulphur-containing bradykinin antagonist compounds of formula (I) and their salts are claimed: one of X1-X3 = COR , and the other X1-X4 = N, CR ; R ,R = H, halo, 1-6C alkyl, OR , SR , NHR , 6-12C aryl, (6-12C aryl)(1-3C alkyl), C(O)OR , C(O)H, 2-5C alkenyl, NO2, SO3R , CN, C(O)NHR , where alkyl, aryl, alkenyl may be substituted by C(O)(O)o(1-5C alkyl), OR , SR , NO2, CN, NHR , halo; R = (II); R ,R = e.g. H; R -R = H, 1-5C alkyl, 3-5C alkenyl, etc.; A = amino acid e.g. methionine, alanine, phenylalanine, etc.; R = H, C(O)(O)o(1-5C alkyl), C(O)(O)o(11-3C alkyl)(6-10C aryl); R = e.g. C(O)DE; D = 2-5C alkendiyl, 1-8C alkandiyl, (CH2)nYo(CH2)m, etc., where any of the groups are optionally substituted by e.g. OR ; E = H, 6-10C aryl, 1-9C heteroaryl, etc.;Y = O, S, NR ; n,m = 0-6; o = 0 or 1.
-
公开(公告)号:DK0560177T3
公开(公告)日:2003-04-14
申请号:DK93103301
申请日:1993-03-02
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , WAGNER ADALBERT DR , SCHOELKENS BERNWARD PROF DR , HEITSCH HOLGER DR , GERHARDS HERMANN DR
IPC: A61K31/4164 , A61K31/64 , A61P9/10 , A61P9/12 , C07D233/84 , A61K31/415 , C07D233/86 , C07D233/90
Abstract: Compounds of the formula (I) in which R is, for example, ethyl, R is, for example, methyl, n is, for example, zero, R is, for example, COOH and R is, for example, SO2NHCONHCH3 are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:GR3033415T3
公开(公告)日:2000-09-29
申请号:GR20000401105
申请日:2000-05-16
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , WAGNER ADALBERT DR , WIRTH KLAUS DR , SCHOELKENS BERNWARD PROF DR , NOELKEN GERHARD DR
IPC: C07D215/48 , A61K31/47 , A61P43/00 , C07D215/26
Abstract: 8-(3-(Aminoalkoxy)-benzyloxy)-quinoline compounds of formula (I) and their salts are new. R1-R3 = H, halo, CHO, COOH, 1-5C alkyl, 6-10C aryl, 1-3C alkyl-(6-10C) aryl, 3-8C cycloalkyl or 1-3C alkoxycarbonyl; R4, R5 = H, halo, NO2, CN, 1-3C alkoxy or 1-3C alkylthio; R6 = H, 1-3C alkyl, 3-5C alkylalkenyl (sic) or 1-3C alkyl-6-10C aryl; R7 = H, 1-6C alkanoyl, alkanoyl (substituted by 1-3C alkoxy, alkylcarbamoyl or aryl), 3-7C alkenoyl, 3-8C cycloalkylcarbonyl, 5-7C cycloalkenylcarbonyl, 1-3C alkoxycarbonyl, aryloxycarbonyl, 6-12C aroyl (optionally substituted by 1-3C alkoxy or halo), alkenoyl (substituted by aryl (optionally substituted by 1-3C alkoxy, 1-3C alkylenedioxy, NO2, CN, halo, 1-3C haloalkyl, hetero-3-8C cycloalkyl (sic), NH2, 1-4C alkylamino, 6-12C heteroaryl-alkanoylamino, aroylamino, 6-12C heteroarylcarbonylamino, 1-5C alkylsulphonylamino, 1-5C alkylureido, alkanoyl, 1-5C alkoxycarbonyl, 1-5C alkylcarbamoyl or arylcarbamoyl), 2-5C acylamino-arylcinnamoyl, 1-3C alkoxycarbonylamino-arylcinnamoyl, 1-4C alkylaminocarbonylaminocinnamoyl, aryl-1-5C alkoxycarbonyl, 1-5C alkylcarbamoyl, arylcarbamoyl, aroylcarbamoyl, alkylsulphonyl, arylsulphonyl, aryl-alkylsulphonyl or phthaloyl (for R6=R7(sic)); n = 1-8; alkyl has 1-6C, aryl has 6-12C, alkanoyl has 2-6C, and alkenoyl has 3-6C unless specified other wise.
-
公开(公告)号:ES2136669T3
公开(公告)日:1999-12-01
申请号:ES94100048
申请日:1994-01-04
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , BHATNAGAR NEERJA DR , BUENDIA JEAN DR , GRIFFOUL CHRISTINE DR
IPC: B01J23/44 , A61K31/235 , A61K31/41 , C07B37/04 , C07B61/00 , C07C41/48 , C07C45/61 , C07C45/71 , C07C47/546 , C07C67/30 , C07C67/343 , C07C69/76 , C07C69/767 , C07C253/30 , C07C255/37 , C07C255/40 , C07C255/56 , C07C303/40 , C07C311/09 , C07C311/48 , C07C311/51 , C07C311/52 , C07C311/53 , C07C311/54 , C07C311/57 , C07C311/58 , C07D257/04
Abstract: The invention relates to a method for the preparation of a compound of the general formula (I) in which X represents an optionally protected formyl group and R denotes a group which is itself inert to the reaction conditions of the synthesis, for example -CN, characterised in that a compound of the general formula (II) where X is as defined above, is reacted with a substituted phenyl halogen compound of the formula (III) where Hal denotes e.g. bromine. The compounds are useful intermediates for pharmaceutical synthesis.
-
公开(公告)号:CZ9800914A3
公开(公告)日:1998-10-14
申请号:CZ91498
申请日:1998-03-25
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , WAGNER ADALBERT DR , WIRTH KLAUS DR , SCHOLKENS BERNWARD PROF DR
IPC: C07D215/24 , A61K31/395 , A61K31/47 , A61K31/495 , A61P1/16 , A61P43/00 , C07D215/26 , C07D241/36 , C07D401/12 , C07D405/12
CPC classification number: C07D401/12 , C07D215/26 , C07D405/12
-
-
-
-
-
-
-
-
-